Cargando…

Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study

Occult breast cancer (OBC) is a special type of breast cancer of an unknown primary origin. Early stage OBC is treated as stage II–III breast cancer. Currently, there are no models for predicting the survival outcomes. Hence, we aimed to evaluate the role of the positive lymph node ratio (PLNR) in O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Di, Zhai, Jingtong, Li, Lixi, Wu, Yun, Ma, Fei, Xu, Binghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698700/ https://www.ncbi.nlm.nih.gov/pubmed/36431280 http://dx.doi.org/10.3390/jcm11226804

Ejemplares similares

Breast Cancer in Chinese Females Aged 25 Years and Younger
por: Li, Lixi, et al.
Publicado: (2021)

High SURF4 expression is associated with poor prognosis of breast cancer
por: Zhai, Jingtong, et al.
Publicado: (2022)

Tumor senescence leads to poor survival and therapeutic resistance in human breast cancer
por: Zhai, Jingtong, et al.
Publicado: (2023)

Antibody-drug conjugates in HER2-positive breast cancer
por: Li, Lixi, et al.
Publicado: (2022)

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers
por: Yi, Zongbi, et al.
Publicado: (2020)

Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis
por: Wu, Yun, et al.
Publicado: (2022)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database
por: Huang, Kai-Yan, et al.
Publicado: (2020)

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
por: Yi, Zongbi, et al.
Publicado: (2019)

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
por: Zhai, Jingtong, et al.
Publicado: (2022)

Prognostic Nomogram for Postoperative Hypopharyngeal Squamous Cell Carcinoma to Assist Decision Making for Adjuvant Chemotherapy
por: Zhang, Di, et al.
Publicado: (2022)

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
por: Yi, Zongbi, et al.
Publicado: (2020)

Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients
por: Qu, Jingkun, et al.
Publicado: (2023)

DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis
por: Rong, Guohua, et al.
Publicado: (2021)

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer
por: Mo, Hongnan, et al.
Publicado: (2020)

Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy
por: Li, Lixi, et al.
Publicado: (2022)

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
por: Mo, Hongnan, et al.
Publicado: (2022)

Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast
por: Zhang, Di, et al.
Publicado: (2022)

Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
por: Li, Zhijun, et al.
Publicado: (2023)

Occult axillary lymph node metastases are of no prognostic significance in breast cancer
por: Millis, R R, et al.
Publicado: (2002)

Occult axillary node metastases in breast cancer: their detection and prognostic significance.
por: McGuckin, M. A., et al.
Publicado: (1996)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
por: Guan, Xiuwen, et al.
Publicado: (2020)

A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-Population
por: Zhu, Yimin, et al.
Publicado: (2022)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population‐based analysis
por: Xu, Hangcheng, et al.
Publicado: (2022)

Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis
por: Wang, Guixin, et al.
Publicado: (2021)

Retrospective literature review of primary neuroendocrine neoplasms of the breast (BNEN) in 209 Chinese patients: Treatment and prognostic factor analysis
por: Chai, Yue, et al.
Publicado: (2022)

The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study
por: Han, Yiqun, et al.
Publicado: (2022)

Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer
por: Chen, Qiongyun, et al.
Publicado: (2020)

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China
por: Yi, Zongbi, et al.
Publicado: (2020)

Occult breast carcinoma presenting with axillary lymphadenopathy
por: Crotch-Harvey, MA
Publicado: (2011)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
por: Yi, Zongbi, et al.
Publicado: (2017)

Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling
por: Li, Cong, et al.
Publicado: (2023)

Syncope as a sign of occult cancers: a population-based cohort study
por: Lorenzen, Mads Okkels Birk, et al.
Publicado: (2019)

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study
por: Ge, Li-Ping, et al.
Publicado: (2018)

Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort
por: Kong, Xiang-Lei, et al.
Publicado: (2016)

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study
por: Liu, Binliang, et al.
Publicado: (2018)

Occult breast cancer: Where are we at?
por: Ofri, Adam, et al.
Publicado: (2020)

Occult breast cancer with pleural metastasis
por: Faghani, Roya, et al.
Publicado: (2023)

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study
por: Zhao, Zijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpdajfd69pronrh5dcm619ckqn